Tina Jonas

About Tina W. Jonas

Independent director of Centrus Energy Corp. since 2020 (age 65), with a distinguished government and private sector career. Former Undersecretary of Defense (Chief Financial Officer/Comptroller) at the U.S. Department of Defense (2004–2008), and later an executive at UnitedHealth Group (President, UnitedHealthcare Military & Veterans; SVP, Operations, Optum, 2012–2014) and Director of Operations at United Technologies’ Sikorsky Aircraft (2008–2010). The Board classifies her as independent and designates her an audit committee financial expert, reflecting deep financial, government contracting, and nuclear/defense expertise .

Past Roles

External Roles

Board Governance

• Independence: Board determined Jonas is independent under NYSE American standards (March 2025). All members of Audit & Finance and CN&G committees are independent .
• Committee assignments (2025): Executive Committee; Audit & Finance Committee; Chair of Compensation, Nominating & Governance (CN&G) Committee .
• Audit committee financial expert: Board designated Jonas (and Rothrock) as “audit committee financial experts” .
• Attendance and engagement: Board held 12 meetings in 2024; all directors attended at least 75% of Board and committee meetings. Annual meeting attendance: all directors except Rothrock attended in 2024; policy expects directors to attend annual meetings .
• Executive sessions: Non‑management directors met regularly in executive session; the independent Chairman presided .
• Cyber oversight: Cyber Risk Committee formed in Dec 2024 (first meeting Mar 2025), strengthening oversight of cybersecurity; Jonas is not a CRC member .

Fixed Compensation

Performance Compensation

Directors do not receive performance-conditioned awards at LEU; annual RSUs for directors vest time‑based. For pay‑for‑performance assessment, LEU ties executive incentives to multi‑metric corporate goals certified by the CN&G Committee.

Other Directorships & Interlocks

• Current public boards: Leidos (LDOS), Virgin Galactic (SPCE); private board: Arete .
• 2024 proxy also lists Serco North America; not listed in 2025 proxy .
• CN&G interlocks: None; no officers on LEU’s CN&G served as executives elsewhere; no compensation committee interlocks reported .

Expertise & Qualifications

• Audit committee financial expert; financially literate .
• Extensive government contracting and defense sector expertise; energy/nuclear experience cited by LEU Board .
• Strategic oversight capability—chairs CN&G, participates in audit and executive committees .

Equity Ownership

Insider Trades

Governance Assessment

• Committee effectiveness: As CN&G Chair, Jonas oversees CEO/senior management pay, non‑employee director pay, governance guidelines, and risk oversight tied to compensation; WTW serves as independent consultant (paid ~$135k in 2024 for CN&G; additional ~$669k for actuarial/benefit work without CN&G involvement), with independence reviewed annually .
• Independence and financial rigor: Independent status, Audit & Finance participation, and “audit committee financial expert” designation bolster board oversight of financial reporting and controls .
• Attendance: Meets minimum engagement standards; Board and committee attendance ≥75% in 2024 across directors .
• Ownership alignment: Director stock ownership guidelines require at least three times annual cash retainer; retention of 50% of shares until target met; hedging and pledging are prohibited, supporting alignment and risk controls .
• Shareholder sentiment: Strong say‑on‑pay approvals reinforce investor confidence. 2024: For 9,400,495; Against 214,726; Abstain 60,787; broker non‑votes 2,386,858 . 2025: For 5,632,737; Against 389,847; Abstain 229,698; broker non‑votes 4,944,410 .

RED FLAGS

• Related‑party transactions: None disclosed involving Jonas; related person policies require CN&G approval; only Dr. Madia’s service engagement noted (affecting his independence) .
• Hedging/pledging: Prohibited under insider trading policy; no pledging disclosed for Jonas .
• Compensation anomalies: Director compensation structure stable; equity grant increased from $100k (FY2023) to $130k (FY2024–2025 term), consistent with market trends; no options or repricing disclosed .

Shareholder Votes (Investor Confidence)

Overall, Tina Jonas presents strong governance credentials—independence, audit financial expertise, and disciplined CN&G leadership—with clear alignment through ownership policies and time‑based director equity. No related‑party or hedging/pledging concerns are disclosed, and shareholder support for compensation has been robust .